The Prevalence of Dietary Supplement Use Among Older Adult Population Using National Health And Nutrition Examination Survey (NHANES) 2009-2012 by Alotaibi, Fawaz M
Virginia Commonwealth University 
VCU Scholars Compass 
Theses and Dissertations Graduate School 
2015 
The Prevalence of Dietary Supplement Use Among Older Adult 
Population Using National Health And Nutrition Examination 
Survey (NHANES) 2009-2012 
Fawaz M. Alotaibi 
Virginia Commonwealth University 
Follow this and additional works at: https://scholarscompass.vcu.edu/etd 
 Part of the Other Pharmacy and Pharmaceutical Sciences Commons 
 
© The Author 
Downloaded from 
https://scholarscompass.vcu.edu/etd/3827 
This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has 
been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. 
For more information, please contact libcompass@vcu.edu. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Fawaz Mutlaq Alotaibi, 2015 
All Rights Reserved 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Prevalence of Dietary Supplement Use Among Older Adult Population Using 
National Health And Nutrition Examination Survey (NHANES) 2009-2012 
 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of 
Pharmaceutical Science at Virginia Commonwealth University 
By 
 
Fawaz Mutlaq Alotaibi  
Pharm-D, King Faisal University, Kingdom of Saudi Arabia 
M.S candidate, 2015  
VCU School of Pharmacy 
Department of Pharmacotherapy and Outcomes Science 
 
 
Advisor 
Dr. Patricia W. Slattum 
Pharm.D, Ph.D. 
Professor and Director of the Geriatric Pharmacotherapy Program 
Department of Pharmacotherapy and Outcomes Science 
 
Virginia Commonwealth University 
Richmond, VA 
May, 2015 
iii 
 
Acknowledgments 
 
   First, I would like to thank God for the endless blessings, well-being, and help 
bestowed on me to accomplish this work.  
    Secondly, I would like to thank Dr. Patricia W. Slattum for giving me this opportunity 
to work under her supervision. From the first day she inspired me to work hard, study 
hard, and to enjoy the field of geriatric. She is the best advisor that every graduate student 
dreams to have. I learned from her first hand research ethics and techniques. I was very 
lucky to know her in my graduate life and have her name today on my thesis as my major 
advisor. Thank you very much Dr. Slattum.  
    Also, I would like to thank Dr.Nadpara and Mr.Scott for their suggestions, advices and 
support from the first day that I asked them to be in my advisory committee. They gave 
me a lot of help and opened their offices for me to stop by at any time without any 
appointment or advance notices.  
    This work will not be completed without my family support. I have two families. The 
first family is at my home country Saudi Arabia. My father and mother who gave me a lot 
of support. I always hear their prayers when I call them every Saturday. I had a very good 
support from my siblings as well and I owe them a lot. I have another family here in the 
United State. Moureq, Ahmad O, A.Hamadah, Bassem, Yoshita, Yeana, Anal shah, 
Emmanuel, Aneta, Brian, Catherin, Cameron, Hind, Iwona, and lots of friends here I 
cannot list them all. I am really blessed having them in my life. Thank you very much to 
both of my families.   
 
iv 
 
    Last but not least, I would like to thank the Ministry of Higher Education, University 
of Dammam, Kingdom of Saudi Arabia for financially supporting my scholarship. I am 
sure without their support I would have not been able to be here pursuing my higher 
education. 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 
Table of Content 
 
Acknowledgments.............................................................................................................. iii 
Table of Content ................................................................................................................. v 
Abbreviations ................................................................................................................... viii 
Abstract ............................................................................................................................ viii 
CHAPTER 1 INTRODUCTION ..................................................................................... 1 
United States Regulation of Dietary Supplements: .................................................................................... 3 
Older Adults in the USA: ................................................................................................................................... 4 
Polypharmacy: ........................................................................................................................................................ 4 
Specific Aims and Significance:....................................................................................................................... 5 
CHAPTER 2 LITERATURE REVIEW ......................................................................... 7 
Literature Review Objectives: ........................................................................................................................... 7 
Search Strategy: ..................................................................................................................................................... 7 
Inclusion Criteria:.................................................................................................................................................. 7 
Exclusion Criteria: ................................................................................................................................................ 8 
Results: ..................................................................................................................................................................... 8 
Review of Methodology Used in the Selected Studies: ............................................................................ 9 
Review of the Prevalence of DS use and the motivation of using DS in the Studies: .................. 12 
Factors Associated with DS use: ................................................................................................................... 14 
Review of concurrent use of prescription medications with DS: ........................................................ 17 
Conclusion: .......................................................................................................................................................... 17 
CHAPTER 3 METHODS............................................................................................... 19 
vi 
 
Aim of the Study: ............................................................................................................................................... 19 
Study Design: ...................................................................................................................................................... 19 
Data Source: ......................................................................................................................................................... 19 
Study Population: ............................................................................................................................................... 21 
Dietary Supplements Information: ................................................................................................................ 21 
Reasons for Using Dietary Supplements: ................................................................................................... 23 
Polypharmacy and Dietary Supplements: ................................................................................................... 23 
Covariates: ............................................................................................................................................................ 23 
Statistical Analyses:........................................................................................................................................... 27 
Ethical Consideration:....................................................................................................................................... 27 
CHAPTER 4: RESULTS ............................................................................................... 29 
Prevalence of dietary supplements use among U.S. population ages 20-64 years using 
NHANES 2009-2012 ........................................................................................................................................ 31 
Prevalence of dietary supplements use among adults 65 years and older using NHANES 2009-
2012 ........................................................................................................................................................................ 35 
Prevalence of use of specific types of dietary supplements and the most common reported 
reason for use of each product among older adults ................................................................................. 39 
The relationship between dietary supplement use and demographic and socioeconomic 
characteristics among older adults ................................................................................................................ 42 
CHAPTER 5: DISCUSSION ......................................................................................... 44 
Trends in DS use ................................................................................................................................................ 44 
Rationale for using DS among older adults ............................................................................................... 45 
Polypharmacy and prescription medications ............................................................................................. 46 
Factors predicting using DS for older adults ............................................................................................. 47 
Strengths ................................................................................................................................................................ 48 
vii 
 
Limitations............................................................................................................................................................ 48 
Future Directions ................................................................................................................................................ 49 
Conclusion ............................................................................................................................................................ 49 
References ........................................................................................................................ 50 
Appendix .......................................................................................................................... 53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
viii 
 
 
Abbreviations 
 
ADRs Adverse Drug Reactions 
BMI Body Mass Index 
DLA Daily Living Activity 
DS Dietary Supplement 
DSA Dietary Supplement Act 
DSHEA Dietary Supplement Health and Education Act 
FDA Food and Drug Administration 
FDCA Food, Drug, and Cosmetic Act 
GAO Government Accountability Office 
GEM Ginkgo Evaluation Memory 
IADL Instrumental Activities of Daily Living 
IRB Institutional Review Board 
MEC Mobile Examination Center 
MVMM Multivitamin-Multimineral 
NHANES National Health and Nutrition Examination Survey 
NHIS National Health Interview Survey 
NSHAP National Social life, Health and Aging Project 
NVDS Non-Vitamin Dietary Supplement 
OTC Over The Counter 
RTCs Randomized Controlled Trial 
USA United State of America 
 
 
 
 
Abstract 
 
 
 
 
THE PREVALENCE OF DIETARY SUPPLEMENT USE AMONG OLDER ADULT 
POPULATION USING NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 
(NHANES) 2009-2012 
 
 
By Fawaz Mutlaq Alotaibi, MS. 
 
 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of 
Pharmaceutical Science at Virginia Commonwealth University 
 
 
Virginia Commonwealth University, 2015 
 
 
Advisor: Patricia Slattum, Pharm.D., Ph.D. 
 Professor and Director of Geriatric Pharmacotherapy Program 
Department of Pharmacotherapy and Outcomes Science 
 
 
Background: Dietary supplements (DS) use has increased in the U.S. in the past 20 years. More 
than half of the U.S. population reported using DS. There are few studies to our knowledge that 
have assessed DS use specifically for older adults. In this study we purposed to evaluate the 
trend of using DS among older adults and to test the association between using DS and several 
demographics, socioeconomics and health characteristics. The second objective was to evaluate 
the reasons behind using DS among older adults using a nationally representative database.    
Methods: This is a cross sectional study using the most recent National Health and Nutrition 
Examination Survey (NHANES) database 2009-2012. It is a nationally representative sample of 
noninstitutionalized adults in the U.S. Frequency and weighted percentage (standard error) were 
 
 
 
 
reported for dichotomous variables. Multiple logistic regressions model analyses were used to 
evaluate the predictors of DS use after testing model assumptions, multicollinearity, and outliers. 
P values 0.05 were considered significant. All the statistical analyses were conducted using SAS 
software version 9.4.    
Results: Out of 2625 older adult participants (65 years and older) 70.5% of them reported using 
DS in the past 30 days. Female, non-hispanic white, obese, overweight and excellent and very 
good self-reported health status participants were more likely to use DS. Multivitamin-
multiminerals (MVMM), calcium and vitamin D were the most commonly reported supplements 
among older adults. 71% of oldest old (80≥ years) reported taking DS and prescription 
medication in the past 30 days concomitantly and 73% of polypharmacy users reported using 
DS. To stay healthy, to improve overall health and for bone health were the most commonly 
reported reasons behind using DS.    
Conclusion: majority of older adult participants reported using DS in the past 30 days. Health 
care professionals need to evaluate the dietary supplement information from older adults in order 
to improve health care. 
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CHAPTER 1 INTRODUCTION 
    This chapter explains the trend of DS use in the past 20 years among U.S. adults, DS 
regulation in the U.S., brief background about older adults in the U.S., polypharmacy related 
issues, and study significance. Chapter 2 reviews the recent studies (2004-2014) that have 
focused on prevalence of DS among U.S. adults. Chapter 3 provides study design, and 
inclusion/exclusion criteria for the study population and statistical analysis methods. Chapter 4 
presents the results of each specific aim. Finally, Chapter 5 provides discussion, strengths, 
limitations, future direction, and conclusion for this project.      
    The 1994 United States Dietary Supplement Health and Education Act (DSHEA) defines the 
term dietary supplement (DS) as “a product taken by mouth that contains a dietary ingredient to 
supplement the diet”(“Q&A on Dietary Supplements,” 2014). Dietary ingredients may include 
vitamins, minerals, herbs or other botanicals, amino acids, enzymes, organ tissue, glandulars, and 
metabolites. Before DSHEA 1994, DS were subject to the same regulatory requirements as other 
foods, but now, under DSHEA 1994, the manufacturer has full responsibility for the safety and 
labeling of DS. The prevalence of DS use in the United States has increased over the years since 
DSHEA 1994 was enacted (Gahche et al., 2011). 
    DS use is common among the U.S. adult population. In the National Health and Nutrition 
Examination Survey NHANES 1988-1994, approximately 44% of the U.S. population reported 
taking DS in the past 30 days (Gahche et al., 2011). In the same study approximately 30% of the 
U.S. population reported taking multivitamins/multiminerals in the past 30 days (Gahche et al., 
2011). After 18 years the percentage has increased to 53% reporting taking DS and 39% 
reporting taking multivitamins/multiminerals in NHANES 2003-2006 (Bailey et al., 2011). 
According to the U.S Government Accountability Office GAO report 2009, the total sales of DS 
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has increased from 14$ billion in 1997 to 22$ billion in 2007 as shown in figure 1-1 (States & 
Accountability, 2009). 
 
Figure 1-1 Total sales of Dietary supplement in the United States from 1997 through 2007 according 
to GAO report. 
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United States Regulation of Dietary Supplements:  
     There are several pieces of legislation that have been enacted to regulate DS use and safety in 
the USA. The major legislation addressing DS use before DSHEA-1994 were the Food, Drug, 
and Cosmetic Act of 1938 (FDCA), the Proxmire Amendment, and the Dietary Supplement Act 
of 1992 (DSA). As DSHEA 1994 is the most recent DS regulation in the USA, a brief review of 
this regulation is discussed below.  
    According to DSHEA-1994, DS have a separate new category of regulation for safety and 
labelling issues, unlike before DSHEA-1994 when DS were subject to the same regulatory 
requirements as other foods. Under DSHEA-1994, a manufacture has the full responsibility to 
make ensure that the DS is safe and properly labeled.  The manufacturer is only required to 
notify FDA if it intends to market a DS that contains a new “dietary ingredient”. In addition, 
FDA requires certain information has to be in the label such as the name of the product, a 
statement that it is a supplement, the name of the manufacturer, a complete list of ingredients, a 
declaration that the supplement does not require FDA review or approval, and the disclaimer 
statement “This statement has not been evaluated by the FDA. This product is not intended to 
diagnose, treat, cure, or prevent any disease”. By DSHEA low, the manufacturer and distributer 
are responsible for investigating and reporting to FDA any report they receive of a serious 
adverse event within 15 days. FDA has the responsibility to show that the DS is unsafe after the 
product is released to the market. That means there are no studies required to be done on the 
product efficacy or safety before introduction to the market.  
    More than half of U.S. adults reported using DS in the past 30 days (Eileen T. Kennedy, Hanqi 
Luo, 2013) and this study shows that reporting using DS increases with age. 42% of U.S. older 
adults (57-85 years old) reported using Over The Counter (OTC) medication in the past 6 months 
(Qato et al., 2014). In addition, 48% of older adults form the same study reported using DS in the 
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past 6 months (Qato et al., 2014). DS prevalence is increasing among older adults due to the 
misperception that DS are safer than OTC or prescription medications, while still the safety and 
efficacy of DS is not well established (Nahin et al., 2009). Cultural, philosophical, and religious 
beliefs play an important role in increasing DS use among U.S adults (Nahin et al., 2009).  
Older Adults in the USA: 
    Older adult is a term referring to a person who is 65 years or older. Today, there are almost 40 
millions persons aged 65 years and older living in the United States and this number is expected 
to increase to 89 millions persons in the next 40 years (Jacobsen, Kent, Lee, & Mather, 2011).  
This rapid change in population characteristics can lead to economic, social, and health care 
consequences, especially if the healthcare system does not prepare for this change (Jacobsen et 
al., 2011). Many older adults have several comorbidities and receive more than one prescription 
medication, which may lead to difficulty managing their health and maintaining their quality of 
life. Also, older adults experience physiologic changes associated with aging affecting their liver 
and kidney function, which make taking DS that have been never tested on this specific 
population potentially more risky and more likely to result in an adverse outcome.   
Polypharmacy:  
    Polypharmacy is also a concern for older adults. The pattern of polypharmacy is expected to 
increase in the next few years among the older adult population. Kaufman et al. found that more 
than half of US older women use more than 5 prescription medications and 12% of them take 
more than 10 medications per day (Hajjar, Cafiero, & Hanlon, 2007). There are several 
definitions of polypharmacy proposed in the literature. Use of six or more medications or using 
at least one potentially inappropriate medication listed on the Beers list (2012) indicating that the 
risk generally outweighs the benefit for most older adults are the most common definitions of 
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polypharmacy. (Riker & Setter, 2012). Polypharmacy is a very important issue among older 
adults because it increases the risk of adverse drug reactions (ADRs) and drug-drug interactions 
(Mallet, Spinewine, & Huang, 2007). Using DS by patients taking prescribed medications will 
increase the risk of DS-drug interactions and ADRs, which may lead to increased rates of 
hospitalization, mortality and morbidity of older adults.    
Specific Aims and Significance:  
    The main objectives of this project are to document the prevalence of DS use among the U.S. 
adult population and older adults specifically, and to identify demographic and socioeconomic 
predictors of DS use by analyzing data available from the National Health and Nutrition 
Examination Survey NHANES 2009-2012.   
The specific aims for this study are:  
1) To determine the prevalence of DS use among older adults 65 years and older using 
NHANES 2009-2012 data.  
    Previous studies have shown that the prevalence of DS use is increased among older adults, 
although those over the age of 71 years have not been included in previous analyses. Older adults 
are at high risk of polypharmacy and comorbidities, increasing their risk of supplement-drug 
interactions or disease-supplement interactions.  
2) To assess the relationship between DS use and demographic and socioeconomic 
characteristics.  
    Identifying characteristics with a significant association with DS use may be helpful to 
improve patient health and patient care by facilitating targeting of health care interventions to 
patients at greatest risk for using DS.    
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3)  To evaluate the reported reasons for using dietary supplements among older adults.  
    Knowing the reasons for DS use in this population may help health care professionals better 
understand why older adults may use DS and identify opportunities to improve the use of DS in 
this population.     
    Several studies have reported the prevalence of DS among all ages in the U.S. adult 
population. However, lack of consistency of defining older adults age interval in those studies 
make it difficult to provide a conclusion specifically for older adults. Most of our objectives in 
this study were focused on older adults (65 years and older). This is the common age interval for 
older adults that has used in the previous studies in the health care field. This study will be the 
first study to evaluate the use of DS specifically among older adults in the U.S. using the most 
recent cohort available from NHANES. The results of the study will contribute to understand the 
most common reported reasons for using DS that have used in the past 30 days. Knowing the 
prevalence and the reasons of DS use may overcome some of the challenges related to DS-drug 
interaction, DS-disease interactions, or unknown side effects that may appear on older adults due 
to DS use. The results of the study will document the extent of use of DS among older adults and 
serve as the basis for further research on the impact of DS use on the health of older Americans. 
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CHAPTER 2 LITERATURE REVIEW 
    This chapter describes recent research findings regarding DS use in the U.S. There are several 
studies that have discussed the trends in DS use among the U.S. population with different clinical 
situations for example, use of DS among cancer patients, use of DS among cardiac disease 
patients, and use of DS in combination with medications to treat certain medical conditions. In 
this literature review only the prevalence or trend of using DS among the general U.S. adult 
population will be discussed, without focusing on a specific disease or population.  
Literature Review Objectives:  
The objectives of this literature review are to: 
- Document the recent prevalence of DS use among the adult U.S. population; 
- Identify confounders and predictor variables that affect DS consumption;  
- Evaluate previous studies and identify “gaps” in the literature in order to inform the design 
of a new study focusing on DS use among older adults in the U.S.; 
Search Strategy:  
    Studies were identified using comprehensive English MeSH terms in PubMed and CINHAL. 
MeSH terms and subheadings used included “Dietary Supplements/Utilization” AND Aged, OR 
80 year and older, OR Frail Elderly. The titles, abstracts, and relevant citations were reviewed, 
and inclusion and exclusion criteria were applied to determine which studies to include in the 
review. 
 Inclusion Criteria:   
- Included older adults (65 years and older)  
- Used recent data or recent publications (from 2004 to 2014) 
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- Used nationally representative databases like NHANES or NSHAP 
- Conducted in the U.S. with the U.S. population. 
Exclusion Criteria: 
- Used specific populations that may limit the generalizability of the results such as focusing 
on DS use among cancer patients or cardiac patients 
- Was conducted outside the U.S. or using non U.S. population  
- Excluded the older adult population 
The Newcastle-Ottawa Quality Assessment scale was used to critically evaluate the studies. This 
tool is appropriate to critique cohort, cross-sectional and case control studies.  
Results:  
    Out of 375 unique articles identified and screened from both databases (PubMed and 
CINHAL), there were six studies that met the inclusion and exclusion criteria. All of them were 
cross-sectional studies. Three studies used NHANES (“National Health and Nutrition 
Examination Survey : Plan and Operations , 1999 – 2010,” 2010), one study used the National 
Health Interview Survey (NHIS) (Services, 1997), one study used the National Social Life, 
Health and Aging Project (NSHAP) (“National Social Life, Health, and Aging Project 
(NSHAP), NORC.org,” 2014), and the last study used data collected for the Ginkgo Evaluation 
Memory (GEM) study (“Questions and Answers: Ginkgo biloba for the Evaluation of Memory 
(GEM) Study, NCCIH,” 2014). Table 2-1 summarizes each study that met the 
inclusion/exclusion criteria. 
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Review of Methodology Used in the Selected Studies:  
   Five of the six studies identified were derived from nationally representative survey-based 
datasets such as NHANES and NHIS. One study used data from a randomized double blind, 
placebo controlled trial (RTC), a multicenter trial to increase the study internal validity, 
reliability. Four reviewed studies were conducted based on noninstitutionalized, household 
population surveys, while two studies were based on community dwelling adults. All of the 
previous studies were inconsistent with defining the older adult age interval even among those 
studies that used the same database. For instance, there were three studies from NHANES and 
the definition of older adult was either from 60-69 years, or greater than 71 years, or greater than 
60 years old. In the GEM study, older adult was defined participants greater than 75 years old, 
while in the NSHAP study, the analysis was based on the older adult population from 56 years 
old to 85 years old. In the NHIS study, the older adult age interval was defined as greater than 
65 years old, which is the same age interval that we used in this study consistent with most of 
the studies in geriatrics field as well. Thus, variability of defining the older adult age interval 
makes comparing the results difficult. 
    DS information is another place that we could see variability between the previous studies. 
All NHANES based studies have used the short term used of DS, which was reported as the DS 
use in past 30 days, while the NSHAP study has used daily or weekly use. GEM study reported 
the DS use within the previous two weeks from the interview day and finally the NHIS study 
considered the DS use for the previous 12 months period. Most of the reviewed studies defined 
DS based on DSHEA definition. DS information was collected via home interview and self 
reported questionnaires among all reviewed studies, which may lead to recall bias or selection 
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bias and may result in overreporting or underreporting of important information related to DS 
use.  
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Table 2-1 Summary of all the previous studies that met the inclusion and exclusion criteria.  
Study  Setting and sample size  Data source  Conclusion  
Kennedy, et al., 2013 Noninstitutionalized 
participants, 20-69 years old. 
Only the population estimate 
was reported. 
NHANES Half of the U.S. population used DS. The 
percentage of DS users increased while the 
participants getting older.  
Bailey, et al., 2010  Noninstitutionalized, 37516 
participants for all ages older 
than 1 year  
NHANES 70% of older adults aged >71 years used DS in 
the past 30 days. The most common supplement 
was a multivitamin/multimineral supplement.  
Bailey, et al., 2013 
 
 
  
Noninstitutionalized, 11956 
adult participants >20 years old  
NHANES  49% of U.S. adult reported using DS in the past 
30 days. 45% of reported reasons for taking DS 
was to improve or 33% to maintain health. Older 
adults were more likely to use DS than younger 
adults.  
Gardiner, et al., 2006 Noninstitutionalized, household 
population. 31044 participants 
(includes 18 years and older. 
NHIS 21% of those who used prescription medications 
also used Nonvitamins dietary supplements 
NVDS in the past 12 months. Being female and 
younger were the factors most strongly 
associated with using NVDS.  
Qato, et al., 2008 Community dwelling persons 
2976 participants (aged 57 to 85 
years) 
NSHAP Among prescription users and OTC users, 68% 
of them also used a DS in the past year.  
Nahin, et al., 2009 Community dwelling older 
adults (>=75 years) 3070 
participants  
GEM 74% of older adults who used prescription 
medications also used at least one DS.  
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    Some studies assessed the prevalence of DS use across all ages, but most of them focused on 
adults over 18 years of age. Two studies were conducted using databases that only included older 
adults in their database such as NHIS and NSHAP. Few studies have examined concurrent use of 
medication and DS along with the prevalence of DS use. Only one study evaluated drug-
supplement interactions among older adults.  This study used Micromedex to define the drug-
supplement interactions included in the analysis.  
Review of the Prevalence of DS use and the motivation of using DS in the Studies:  
    Bailey et al. in the most recent study conducted using NHANES (2007-2010) found that 49% 
of U.S. adults over 20 years old reported using DS in the past 30 days (Bailey, Gahche, Miller, 
Thomas, & Dwyer, 2013). 67% of older adults (>60 years old) were DS users in Bailey study 
(Bailey et al., 2013). Female, older adults (>60 years old), non-hispanic white, normal BMI, 
highly income participants, former smokers, self reported excellent or very good health status 
were more likely to report using DS than other population (Bailey et al., 2013). Multivitamin-
multiminerals (MVMM), calcium, omega-3/fish oil, and botanicals were the top 4 DS reported 
in the same study by 32%, 11.6%, 10%, and 7.5% respectively. Kennedy et al. found in the 
second most recent study using (NHANES 2007-2008) that almost 50% of the U.S. population 
used at least one DS in the past 30 days (Eileen T. Kennedy, Hanqi Luo, 2013). In the same 
study the percentage of DS use was increasing while the age of the U.S. population is increasing 
as well. In the same study the authors found that DS use was more likely in females, older 
adults, highly educated people (having college graduate degree or above), and non-hispanic 
whites (Eileen T. Kennedy, Hanqi Luo, 2013). Bailey, et al. found similar results using an 
earlier NHANES cohort (2006); 49% of the U.S population used at least one DS in the past 30 
days (Bailey et al., 2011). Eighty percent of those users reported taking the DS every day during 
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the past 30 days. Females, older adults (greater than 71 years old), highly educated people 
(having greater than high school degree), and overweight participants were more likely to use 
DS in this study (Bailey et al., 2011). Multivitamins and multiminerals (MVMM) was the 
highest reported DS use at 33%, followed by botanical supplements used by 14%.    Because 
there was limited information available regarding DS use and concurrent use of prescription 
medication among older adults, Qato, et al. conducted a study to determine the prevalence of 
prescription medication and DS use among older adult in the U.S. and evaluate drug-supplement 
interactions. This study used the NSHAP database of older adults aged 57 to 85 years. Forty-
nine percent of this population was reported using DS (Qato et al., 2008). In this study, 68% of 
the population was using DS and prescription medication concurrently, which may lead to 
adverse events due to drug-supplement interactions or disease-supplement interactions 
especially among older adults who often have more than one medical condition and take 
multiple prescription medications (Qato et al., 2008).  Consistent with this study, Nahin et al. 
evaluated the concomitant use of prescription drugs and DS in ambulatory older people (≥75 
years old) using data collected as part of the GEM study. Nahin et al, found that almost 82.5% 
of study participants used at least one DS and 55% using three or more DS with an average of 
three DS per participant (Nahin et al., 2009). Ninety percent of DS users were reported using at 
least one prescription medication, and among all study participants 75% of them reported using 
at least one DS and one prescription medication (Richard.L. et al., 2009). Multivitamins, iron, 
and vitamin E were the most commonly used DS among older adults at 60%, 59%, and 44% 
respectively (Richard.L. et al., 2009).   
    From NHIS, Paula, et al. found that 21% of those who used prescription medications also 
used non-vitamin DS (NVDS) in the past 12 months (P Gardiner, Graham, Legedza, Eisenberg, 
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& Phillips, 2006).  Unlike previous studies, Paula et al. found that younger participants (≤24 
years old) were more likely to use NVDS compared to older adults (≥65 years old) or middle 
aged (45-54 years old) participants. Also Paula found that NVDS use was more common among 
those with non-life threatening conditions such as menopause, insomnia, and chronic pain (P 
Gardiner et al., 2006). Among all the previous studies there was only one study that examined 
the reasons of using DS among >20 years old U.S. population using (NHANES 2007-2010). To 
improve overall health, to stay healthy, for bone health, to supplement the diet, and to prevent 
health problems were the top 5 reasons for using DS among U.S. adults by 45%, 33%, 25%, 
22%, 20.5% respectively (Bailey et al., 2013).    
Factors Associated with DS use: 
    Table 2-2 shows the list of the factors that have been evaluated with DS users in the previous 
studies. Only seven factors were significantly associated with DS users among all ages including 
age, race, education, gender, BMI, family income, and region. The rest of the 22 variables they 
studied were not significantly associated with DS users.  
    Most studies agreed that older adults consume more DS and alternative medicine than 
younger age groups (Bailey et al., 2013) (Eileen T. Kennedy, Hanqi Luo, 2013) (Bailey et al., 
2011) (Qato et al., 2008). In addition, females, highly educated participants, non-hispanic 
whites, and insured participants were more likely to use DS. Gardiner et al. examined the factors 
associated with DS use only among those who take prescription medications (P Gardiner et al., 
2006). Paula et al found that females, cigarette smokers, hispanic or non-hispanic whites, and 
those living in the West (compared to the Northeast) were more likely to use nonvitamin dietary 
supplements (NVDS). Surprisingly, in the same study they found that younger participants were 
more likely to use NVDS compare to older adults or middle aged individuals (P Gardiner et al., 
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2006).  Also, the study showed that prescription users for menopause, insomnia, chronic pain, 
and sever headache tend to use NVDS greater than those who used prescription medications for 
hypertension, hyperlipidemia, or diabetes. (P Gardiner et al., 2006).  
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Table 2-2 Factors that have been evaluated with DS use in the previous studies. 
Factor  Kennedy, 
2013 
Bailey,2010 Bailey,2013 Gardiner, Qato, Nahin, 
Age*              
Race*             
Gender*              
Education*             
BMI*            
Income*            
Smoking           
Health Insurance           
Exercise           
Health status           
Chronic condition          
Household food security 
status  
       
Household food benefit         
Alcohol use          
Region*         
Usual source of medical         
Last visit to health 
professional  
       
Church attendance         
Club attendance         
Reading senior magazine         
Reading Bible         
Difficulties of DLA or 
IDLA  
       
*variables were significantly associated with DS in the previous studies at 0.005 level of significant.  
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Review of concurrent use of prescription medications with DS:  
    Three of the studies examined concomitant use of DS with prescription drugs. A study by 
Qato et al, showed that 68% of older adults used DS in combination with prescription 
medications (Qato et al., 2008). In the GEM randomized control trial, Nahin et al., found that 
83% of older adult medication users also used DS (Richard.L. et al., 2009). Moreover, the same 
study showed that 90% of DS users have also used prescription medications (Nahin et al., 2009). 
Aspirin, statin medications, and beta blockers were the most frequent medications that were 
combined with DS (Richard.L. et al., 2009). The study by Gardiner et al. showed that only 21% 
of prescription medication users also used NVDS in the past 12 months, but this study only 
focused on NVDS without examining all DS as considered in the other two studies(P Gardiner 
et al., 2006). There are few studies examining the concomitant use of prescription medications 
and DS among older adults, and more work in this area is needed.  Possible adverse 
consequences associated with concomitant use of prescription medications and DS are also 
poorly understood.     
Conclusion:  
    This review was conducted to assess the current literature evaluating the prevalence of DS 
among the U.S. older adult population using nationally representatives databases. Twelve 
studies were identified but only six studies were conducted within the most recent 10 years 
period (2004-2014). This specific time period was focused on because the current prevalence is 
most likely to be related to the more recent studies that have been conducted. These previous 
research studies conducted in the past decade used nationally representative datasets that are 
well-documented methodologically such as NHANES, and NHIS. Only one study focused 
exclusively on NVDS (Paula Gardiner et al., 2014). Three articles examined the use of DS 
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among prescription medication users. One study was focused on the most commonly reported 
motivations for using DS among U.S. adults population.  
    The most recent study that evaluated the patterns of use of DS among the U.S. population 
used the 2010 NHANES cohort. Most of the studies found that using DS was more likely among 
older adults, females, highly educated participants, insured individuals, and overweight people. 
Age, sex, marital status, level of education, annual family income, race/ethnicity, health 
insurance, smoking status, body mass index, and region of U.S. resident were the most common 
variables tested in the previous studies. In addition, more predictors were evaluated in our study 
like polypharmacy, concomitant use of prescription medications and DS, and hypertensive 
participants. Those three factors were associated in previous studies with an increased rate of 
drug-drug interactions and adverse drug reactions (Brazier & Levine, 2003). While most of the 
previous studies agreed that older adults were more likely to use DS, there is need for a study 
using more recent data conducted specifically in this population. All the reasons and factors 
associated with reported DS in the previous studies were tested among all ages not only for 
older adults. For that reasons conducting a specific study in the older adults population is 
necessary. Older adults are generally at greater risk for drug-drug interactions, drug-supplement 
interactions, disease-supplement interactions, and polypharmacy due to multiple health 
conditions (Brazier & Levine, 2003). It is very important to focus on this population to 
ultimately minimize the risk of ADRs and unnecessary medication use, as well as improve 
quality of life.      
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CHAPTER 3 METHODS 
    This chapter details the study design, population of interest, included variables, and statistical 
analyses methods used to conduct this study.     
Aim of the Study: 
    There are three main objectives in this project: 
1- To determine the prevalence of dietary supplements use among older adults 65 years and 
older in the U.S. using NHANES 2009-2012 data.  
2- To assess the relationship between dietary supplement use and demographic and 
socioeconomic characteristics among the U.S. older adult population (aged 65 years and 
older).  
3- To evaluate the most commonly reported reasons for using dietary supplements among 
older adults in the U.S. 
Study Design:  
    A retrospective cross sectional study design was used to conduct this study using NHANES 
(2009-2010 and 2011-2012) cohorts. These are the most current data available publicly for 
NHANES and will provide the most up-to-date picture of DS use among the U.S. population in 
general and older adults specifically using NHANES.    
Data Source: 
    NHANES is a survey that is designed to assess health and nutritional status of adults and 
children in the United States (“National Health and Nutrition Examination Survey : Plan and 
Operations , 1999 – 2010,” 2010).  This data is the only free publicly available data source that 
contains a separate dietary information file, including DS use and some details about the DS use. 
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This survey examines a nationally representative sample of approximately 5000 persons each 
year using a complex, stratified, and non-institutional cluster sample design that allows for 
generalization to the entire U.S. population (“National Health and Nutrition Examination 
Survey : Plan and Operations , 1999 – 2010,” 2010). NHANES participants were selected 
randomly using a computerized system following these four stages. First was county selection, 
second was selection of a block within that county, third was selection of a specific household 
within that block, last stage was selection of individuals within a household. Computer-assisted 
personal interview system and Blaise software was used to assess the qualified participants 
within each household. More detail about sample selection can be find in the NHANES Plan and 
Operations manual (“National Health and Nutrition Examination Survey : Plan and Operations , 
1999 – 2010,” 2010). One unique aspect of this data is that it contains both the dietary 
information collected from household interview and examination information collected via the 
Mobile Examination Center (MEC). It has five main files, including a demographic file, 
examination file, laboratory file, questionnaire file, and dietary file. Only four files were used to 
conduct this study (demographic file, examination file, questionnaire file, and dietary file). The 
overall unweighted interviewed response rate for NHANES 2009-2010 was 79.4%, while the 
response rate for NHANES 2011-2012 was 72.6% for all ages.  
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Study Population:  
    The study population consisted of non-institutionalized adults who completed the dietary 
information survey from age 20 years through 80 years old and older. Individuals aged 80 and 
older are not identified by their specific age to protect their privacy.  
Inclusion Criteria:  
- All individuals age of 20 years and older  
Exclusion Criteria:  
- Children 19 years old or younger   
Dietary Supplements Information: 
    The questionnaire survey includes many topics related to health like, DS used, medications 
used, and medical conditions. The most important file needed to conduct this study was the DS 
file. NHANES has two DS files, the first one related to the individual DS information, which has 
the supplement details and the motivations for each supplement. The second file was related to 
the total DS information, which has the question related to DS use and the frequency of the 
supplement that has used in the past 30 days. Both files are needed to conduct this study.  The 
DS use information was collected during the household interview process. The interviewer asked 
the participants “Have you used or taken any vitamins, minerals, or other dietary supplements in 
the past month?”. If the participants answered yes, the interviewer asked to see the DS container 
(Figure 3-1). If the bottle was not available, participants were asked to recall the name of the 
DS. Additional questions related to DS use were asked such as “Was the DS recommended by a 
physician, colleague or friends, or chosen on your own?”.  Answers to these questions were 
evaluated as part of this analysis. All of this information was obtained from individual and total 
DS files (DSQIND, DSQTOT). 
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Figure 3-1 The process of how the DS information was collected in NHANES survey 2009-2012. 
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Reasons for Using Dietary Supplements:  
    This DS information was collected during the household interview process. In the 
questionnaire, more than 30 options for reasons for using DS in the past 30 days were provided. 
In this study, the top reported reason for each individual DS was evaluated. Also, the most 
common reasons that were reported in general were studied. Any reason that had less than 100 
observations was recoded as “other”. The Reasons for using DS are listed in Table 3-1.   
Polypharmacy and Dietary Supplements:  
    Polypharmacy was defined as using 4 or more prescription medications (Bikowski, Ripsin, & 
Lorraine, 2001) (Fulton & Allen, 2005). This information on medication use was obtained from 
the Questionnaire file. Medication file only has prescription medications, which needed a 
physician to be prescribed. Over the counter medications and DS are listed in separate files. The 
interviewer asked the participants if they had taken any prescription medication in the past 30 
days. The response to this question is dichotomous (yes/no). Another important variable was the 
number of prescription medications that each participant was using regularly in the past 30 days. 
Any participants that were using 4 or more prescription medications we categorized as a 
“polypharmacy” patient. All of this information was obtained from the medication file 
(RXQ_RX).   
Covariates:  
    All demographic factors were tested in the descriptive and analytical analysis. Demographic 
characteristics included age, race/ethnicity, gender, marital status, annual family income, and 
education level. These were the most common variables evaluated in previous studies examining 
similar objectives as this study.  All of these variables were categorized as in previous studies or 
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according to the number of observations in each group to facilitate comparisons with previous 
studies. If any category in any variable had a small number of observations, we categorized that 
group as “other”. Age was truncate  by NHANES at 80 years and we categorized the age variable 
into six groups, from 20-39 years, 40-64 years, and older adults as 65 years and older (65-69, 70-
74, 75-79, and 80≥). Race/ethnicity was categorized as non-hispanic white, non-hispanic black, 
Mexican American/other hispanic, and other. Education level was categorized as high school or 
less, undergraduate degree, and graduate degrees. Other variables included self reported health 
status (excellent/very good, good, fair/poor), using antihypertensive medication (yes/no), and 
polypharmacy (yes/no) if the participant was taking 4 or more medications in the past 30 days. 
Systolic and diastolic blood pressure elevation were assessed by taking the mean of four systolic 
readings and the mean of diastolic readings. It is considered systolic elevation if the mean four 
readings was greater than 140, and considered diastolic elevation if the mean four readings was 
greater than 90.  Any responses provided as “Refused”, “Don’t Know”, or “Missing” information 
were recoded as missing information. All the vitamins and minerals were recoded according to 
Table 3-1. Concatenating each two files was done first then merging all the files under one 
dataset by the common identifier (SEQN). For example, concatenating two DEMO files (DEMO 
2009 and DEMO 2012) then merging the DEMO file with the rest of the files that we cleaned up. 
We exclude any variable that had large numbers of missing observations like the cholesterol 
diagnosis variable had more than 3000 missing observation. After completing all the data 
cleaning and recoding each variable, SAS codes were reviewed by a SAS expert as a second 
check.  
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Table 3-1 Variables used in the analyses according to NHANES manual book.  
File name  Variable name  Variable description* 
1- DEMO1 RIDAGEYR Age at screening  
 RIAGENDR Gender  
 RIDRETH1 Race/ethnicity  
 DMDMARTL Marital status  
 INDFMIN2 Annual family income  
 RIDEXPRG Pregnancy status at exam  
 DMDEDUC2 Education level  
2- DSQIDS2 DSDSUPP Supplement name  
 DSQ124  Took product on own or 
doctor advice  
 DSQ128A For good bowel  
 DSQ128C For mental health  
 DSQ128D To prevent health problems  
 DSQ128E To improve overall health  
 DSQ128F For teeth  
 DSQ128G To supplement the diet  
 DSQ128H To maintain health/To stay 
healthy  
 DSQ128I To prevent cold  
 DSQ128J For heart health  
 DSQ128K For eye health  
 DSQ128L For healthy joints  
 DSQ128M For skin health  
 DSQ128N For weight loss  
 DSQ128O For bone health  
 DSQ128P To get more energy  
 DSQ128R For anemia (low iron)  
 DSQ128T To maintain blood sugar  
 DSQ128U For healthy hair  
 DSQ128V For kidney and bladder health  
 DSQ128W For respiratory health  
 DSQ128X For allergies  
 DSQ128Z Improve digestion  
 DSQ128AA For menopause  
 DSQ128BB For muscle related issues  
 DSQ128DD For stress and relaxation  
 DSQ128EE For CNS health  
 DSQ128FF For liver health  
 DSQ128GG Antioxidants  
 DSQ128II For gout health  
 DSQ128S Other  
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3-DSQTOT3 DSDCOUNT Total number or DS taken 
 DSD010  Any DS taken  
4-BMX 4 BMXBMI  Body mass index  
5-BPQ5  BPXSY1,BPXSY2, BPXSY3, 
BPXSY4.  
1st Systolic blood pressure 
reading and 2nd, 3rd, and 4th    
 BPXDI1, BPXDI2, BPXDI3, 
BPXDI4.  
1st Diastolic blood pressure 
reading and 2nd, 3rd, and 4th    
 BPQ040A  Taking prescribed medication 
for hypertension 
 BPQ090D  Doctor told you to take 
prescribed medication for 
cholesterol  
6-HSQ6 HSD010  General health condition  
7-RXQ_RX7 RXDUSE Taken prescription medication 
in the past 30 days?  
 RXDCOUNT  Number of prescription 
medications taken?  
* According to NHANES manual. 1 Demographic file, 2 Dietary supplement individual file, 3 Dietary supplement total file in the 
past 30 days, 4 Measurements file, 5 Blood pressure and cholesterol file, 6 Health status file, 7 Prescription medication file.   
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Statistical Analyses:  
    All statistical analyses were performed using SAS version 9.4. The combined NHANES 
databases (2009-2012) were used to determine the weighted trend of DS use among all adult 
ages and older adults specifically. Weighted frequency and row percentage of demographic and 
socioeconomics characteristics were reported. In order to assess the association between 
demographic and socioeconomic variables with DS use, multiple logistic regressions was 
performed. Bivariate analysis and checking that the assumptions for multiple logistic regression 
were performed before running the model. Two important assumptions were tested for each 
variable. The first one was testing if the predictors linearly related to the log of odds of the 
outcomes by performing the Lemeshow Goodness of fit test. The second test was checking if 
there are any influential observations in each variable. Multicollinearity and outlier observations 
were tested. Table 3-2 details how each supplement was categorized. Because a complex, 
multistage sampling design was used to determine a representative conclusion about DS use 
among U.S. population, PROC SUREVYFREQ with STRATA, CLUSTER, and WIEGHT for the 
measurement file were used. DOMAIN statement was used in order to account for the entire 
sample for variance estimation. The variables included in the model were based on previous 
studies or theoretical relationships between the outcome and the predictors. Chi-square was 
calculated to assess the relationship between the outcome variables and the rest of the covariates 
using p-value 0.05 as the level of significance.  
Ethical Consideration:  
    Due to using a publicly available de-identified data source this study met the definition of 
exempt study, which was not necessary to be reviewed by Virginia Commonwealth University, 
Institutional Review Board.  
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Table 3-2 Classification created for most of the dietary supplement in NHANES (2009-2012). 
Category  Definition  Examples 
Multi-vitamin, Multi-mineral (MVMM)  Any product contains both multi-vitamin, and multi-mineral, OR 
any product has three or more vitamins and one mineral 
supplement  
B-complex, 
Centrum, and Tri, 
Vi, Flor 
Multi-vitamins (MV)  Any product contains two or more vitamins without containing any 
mineral supplement  
Multi-vitamin, 2 
Vitamin C and D 
Calcium products  All products that have calcium as a primary supplement.  Calcium, Calcium 
and magnesium 
Fatty acid  All products that contain OMEGA-3 or fatty acids OMEGA-3  
Fiber and colon health  Any laxative product or product that contain fiber supplement  Metamucil Fiber 
Capsules 
Botanicals  Any herbal product or products have botanical ingredient without 
vitamins or minerals  
Garlic, Ginger, 
Gingko Biloba, 
Ginseng  
Joints supplements  Any product contains joint supplement like glucosamine, MSM,  
or both  
Glucosamine, 
MSM 
Single supplements  Any single supplement without any combination with other 
vitamins or minerals or botanicals  
Vitamin C, B, D, 
and Iron  
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CHAPTER 4: RESULTS 
    This chapter describes the results from the analysis conducted for each aim described 
previously. All the results were obtained using the most recent NHANES cohorts (2009-2012) 
available. The purpose of combining two cohorts (2009-10 and 2011-122) was to increase the 
number of participants, especially the older adult group. NHANES is a complex design cohort 
for the non-institutionalized U.S. population, which allows our results to be generalized to the 
U.S. adult population. The data was obtained from the CDC website and is freely available for 
public use. In this study, the dietary file, demographic file, questionnaire file, and examination 
file were used for the analysis. The main variables in this study were obtained from the 
demographic and dietary files. After cleaning and recoding “Unknown” “Refused to answer” or 
any inappropriate responding in each variable or observation and deleting the missing 
information, we ended up with n=11,372 participants. Figure 4-1 and Figure 4-2 details about 
the sample size distribution among both younger and older adults. Any variable having more 
than 5% missing values was deleted according to listwise deletion method.   
Overall, out of 11,372 participants approximately half of them used at least one DS in the past 30 
days (50.83%) (Table 4-1). In our analyses we focused only on those who were using DS in the 
past month to evaluate the trend of DS use among the U.S. population.  
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Table 4-1 Prevalence of DS in the United State among all ages ≥20 years old using NHANES, 2009-
2012. 
DS use  Frequency  Weighted % 
YES  5934 50.83%  
NO  5438 49.16% 
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Prevalence of dietary supplements use among U.S. population ages 20-64 years using 
NHANES 2009-2012 
    Table 4-2 shows the descriptive characteristics of those who were using DS among the 
younger adult population. Of the 11372 participants included in the study, only 8747 fell in the 
younger population category (20-64 years) and this number were examined for this aim. Sample 
frequency and weighted percentage were used to present these results. 46.61% of the younger 
adult population reported taking at least one DS in the past 30 days. 56% of the younger adult 
population was between 40-64 years of age and was more likely to use DS compared to 40% of 
those between 20-39 years of age (Figure:4-1). Among this age group females were more likely 
to report using DS than males (52% vs. 41%). Reported DS use by race is as follows: non-
hispanic whites (51%), non-hispanic blacks (38%), Mexican American and other hispanic (32%), 
and other (49%). Among the younger adult population, normal weight participants were more 
likely to report using DS than underweight, overweight, and obese, (51%, 39%, 48%, and 42% 
respectively). Moreover, as the family income increased, the percentage reporting DS use 
increased from low to middle, and high family income (36%, 46%, 58% respectively). Also, as 
the participants increased in the level of education, the percentage reporting DS use increased as 
well (35% high school or less, 48% college degree, 60% graduate degree). The self reported 
health status distribution was 54% reporting having excellent or very good health, 42% good 
health and 41% fair or poor health. Half of the married participants reported using DS similarly 
with divorced participants and 39% of the participants that they never married reported using DS 
in the past 30 days.   
    In addition, 49% of the younger adult respondents (20-64 years) having either elevated 
systolic or diastolic blood pressure also reported using DS. Fifty three percent of those who were 
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taking antihypertensive medications reported taking DS. The differences between the groups in 
each variable were statistically significant at 0.05 level of significant except the systolic/diastolic 
elevation variable and treatment for hypertension, which were not significant. 
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Figure4-1 Flow chart showing the distribution of the younger population (20-64 years old) who reported using DS in NHANES 2009-12
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Table 4-2 Prevalence and characteristics of those who reported using DS in the past 30 days among 
the younger adult population (20-64 years), NHANES 2009-2012. 
Characteristic  DS use in the past 30 days  
Yes 
Freqa        W.%(SE)b                         
No 
Freqa    W.%(SE)b 
Age*  
20-39 
40-64 
 
1789 
1936 
 
40 (1.3) 
56 (1.3) 
 
3120 
1902 
  
60 (1.3) 
44 (1.3) 
Sex* 
Male  
Female  
 
1571 
2154 
 
41 (1.2) 
52 (1.1) 
 
2669 
2353 
 
59 (1.2) 
48 (1.1) 
Race*  
Non-Hispanic white  
Non-Hispanic black  
Mexican American/other Hispanic  
Other  
 
1621 
773 
821 
510 
 
51 (1.1) 
38 (1.1) 
32 (1.2) 
49 (2.2) 
 
1781 
1215 
1497 
529 
 
48 (1.1) 
62 (1.1) 
67 (1.2) 
50 (2.2) 
BMI* 
Underweight  
Normal  
Overweight  
Obese 
 
54 
1112 
1216 
1306 
 
39 (4.6) 
51 (1.7) 
48 (1.6) 
42 (1.1) 
 
90 
1371 
1600 
1918 
 
61 (4.6) 
49 (1.7) 
52 (1.6) 
58 (1.1) 
Family income* 
Low  
Middle  
High 
 
1378 
1064 
1123 
 
36 (1.2) 
46 (1.5) 
58 (1.6) 
 
2483 
1398 
909 
 
64 (1.2) 
53 (1.5) 
42 (1.6) 
Education* 
High school or less  
College degree 
Graduate degree  
 
1299 
1224 
1197 
 
35 (1.3) 
48 (1.4) 
60 (1.5) 
 
2692 
1441 
884 
 
65 (1.3) 
52 (1.4) 
40 (1.5) 
Systolic/Diastolic elevation  
Yes  
No  
 
454 
3108 
 
49 (2.5) 
47 (1.1) 
 
616 
4141 
 
51 (2.5) 
53 (1.1) 
Antihypertensive medications 
Yes  
No  
 
932 
181 
 
53 (1.6) 
45 (3.0) 
 
940 
261 
 
47 (1.6) 
55 (3.0) 
Health status* 
Excellent/ very good 
Good 
Fair OR poor 
 
1398 
1267 
642 
 
54 (1.1) 
42 (1.6) 
41 (1.9) 
 
1461 
1808 
1078 
 
46 (1.1) 
57 (1.6) 
59 (1.9) 
Marital status* 
Married  
Never married  
Divorced/widowed/separated  
 
2245 
774 
702 
 
49 (1.3) 
39 (1.6) 
50 (1.5) 
 
2880 
1325 
815 
 
51 (1.3) 
61 (1.6) 
50 (1.5) 
*Significant values at 0.05 level of significant using Chi square p-value. a sample frequency. b 
weighted percentage and Standard errors. 
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Prevalence of dietary supplements use among adults 65 years and older using NHANES 
2009-2012 
    For this analysis, only the participants who were 65 years and older at the time of screening 
and interview were included, and the total sample size was 2625 (Figure 4-2). Table 4-3 shows 
the descriptive characteristics of older adults who were using DS in the past 30 days and those 
who were using prescription medications with DS concurrently. The percentage reporting using 
DS increased as the participants got older; 66% for 65-69, 42% for 70-74, 70% for 75-79, and 
74% for 80≥. Among older females, 74% reported using DS in the past 30 days compared to 
65% among male participants. Similar to the younger population, 74% of non-hispanic whites 
reported using DS. Underweight older participants were more likely to use DS than normal 
weight individuals. Also, similar to the younger population, as the family income increased the 
percentage reporting DS use increased (65% for low, 75% for middle, and 74% for high family 
income). 75% of graduate degree holders reported using DS in the past 30 days compared to 
65% among high school degree holders. 74% of older adults who reported excellent or very good 
health status reported using DS compared to 60% of those who reported fair or poor health 
status. 70% of married participants and 72% of divorced participants reported using DS in the 
past 30 days.  
    Seventy percent of older adults with elevation in systolic or diastolic blood pressure reported 
using DS and 72% of older adult antihypertensive medication users reported using DS.  
    Seventy two percent of older adult prescription users reported using at least one DS in the past 
30 days. Also, 73% of older adult who were taking four or more medications reported using DS 
in the past 30 days. 63% of older adults reported deciding to take DS on their own, while 37% of 
them reported taking DS based on their physician’s advice.   
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    In addition, Table 4-3 shows the characteristics of the older adult participants who reported 
using at least one prescription medication plus one DS in the past 30 days. The oldest old (80 
years old), females, non-hispanic whites, underweight, high family income, reported using 
antihypertensive medications, and taking four or more prescription medications are more likely 
to report using prescription medication along with DS in the past 30 days.     
 
 
Figure 4-2 Flow chart showing the distribution of the older adult population (65 years old) who 
reported using DS in NHANES 2009-2012 
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Table 4-3 The Prevalence and characteristics of those who reported using DS in the past 30 days and 
those who reported both DS and prescription medications among the population 65 years and older, 
NHANES 2009-2012. 
Characteristic  DS use in the past 30 days  Use of Prescription medications with 
DS in the past 30 days  
Yes 
Freqa    W.%(SE)b 
No 
Freqa    W.%(SE)b 
Yes 
Freqa    W.%(SE)b 
No 
Freqa    W.%(SE)b 
Age(years)*  
65-69 
70-74 
75-79 
80≥ 
 
443 
453 
307 
510 
 
66 (2.7) 
42 (2.0) 
70 (2.2) 
74 (1.5) 
 
305 
227 
168 
212 
  
34 (2.7) 
27 (2.0) 
30 (2.2) 
25 (1.5) 
 
386 
413 
285 
490 
 
59 (2.3) 
66 (2.2) 
64 (2.6) 
71 (1.8) 
 
361 
267 
190 
230 
 
41 (2.3) 
34 (2.2) 
36 (2.6) 
28 (1.8) 
Sex* 
Male  
Female  
 
782 
931 
 
65 (1.8) 
74 (1.2) 
 
521 
391 
 
34 (1.8) 
25 (1.2) 
 
704 
807 
 
59 (1.9) 
70 (1.1) 
 
598 
450 
 
41 (1.9) 
30 (1.1) 
Race*  
Non-Hispanic white  
Non-Hispanic black  
Mexican American/other Hispanic  
Other  
 
1047 
294 
250 
122 
 
74 (1.4) 
58 (2.5) 
54 (2.4) 
58 (7.4) 
 
408 
217 
208 
79 
 
26 (1.4) 
42 (2.5) 
46 (2.4) 
42 (7.4) 
 
965 
277 
225 
107 
 
68 (1.5) 
56 (2.7) 
50 (2.3) 
53 (7.2) 
 
488 
234 
232 
94 
 
32 (1.5) 
44 (2.7) 
50 (2.3) 
47 (7.2) 
BMI 
Underweight  
Normal  
Overweight  
Obese 
 
29 
469 
598 
574 
 
79 (5.2) 
73 (1.9) 
70 (2.1) 
68 (1.9) 
 
17 
218 
327 
326 
 
21 (5.2) 
27 (1.9) 
30 (2.1) 
32 (1.9) 
 
24 
411 
552 
548 
 
67 (7.7) 
65 (2.3) 
65 (1.9) 
65 (2.3) 
 
22 
276 
372 
351 
 
33 (7.7) 
35 (2.3) 
35 (1.9) 
35 (2.3) 
Family income*  
Low  
Middle  
High 
 
774 
574 
278 
 
65 (1.6) 
75 (1.9) 
74 (3.1) 
 
525 
231 
104 
 
35 (1.6) 
25 (1.9) 
26 (3.1) 
 
711 
523 
259 
 
60 (1.5) 
69 (2.0) 
69 (3.3) 
 
586 
282 
122 
 
40 (1.5) 
31 (2.0) 
31 (3.3) 
Education*  
High school or less  
College degree 
Graduate degree  
 
890 
460 
358 
 
65 (1.5) 
75 (2.1) 
75 (2.5) 
 
610 
172 
127 
 
35 (1.5) 
24 (2.1) 
24 (2.5) 
 
825 
429 
316 
 
61 (1.5) 
71 (2.4) 
67 (2.8) 
 
674 
203 
167 
 
39 (1.5) 
29 (2.4) 
32 (2.8) 
Systolic/Diastolic elevation  
Yes  
No  
 
579 
1059 
 
70 (1.7) 
70 (1.6) 
 
328 
550 
 
29 (1.7) 
29 (1.6) 
 
534 
973 
 
65 (2.0) 
65 (1.6) 
 
372 
633 
 
35 (2.0) 
35 (1.6) 
Antihypertensive medications  
Yes  
No  
 
1121 
33 
 
72 (1.7) 
71 (8.1) 
 
546 
23 
 
28 (1.7) 
29 (8.1) 
 
1106 
30 
 
72 (1.7) 
67 (8.1) 
 
559 
26 
 
28 (1.7) 
33 (8.1) 
Health status*  
Excellent/ very good 
Good 
Fair OR poor 
 
558 
623 
397 
 
74 (1.6) 
72 (2.0) 
60 (2.1) 
 
213 
304 
301 
 
26 (1.6) 
27 (2.0) 
39 (2.1) 
 
492 
589 
370 
 
65 (1.9) 
70 (2.0) 
57 (2.3) 
 
279 
337 
326 
 
34 (1.9) 
30 (2.0) 
42 (2.3) 
Marital status  
Married  
Never married  
Divorced/widowed/separated 
 
960 
66 
685 
 
70 (1.4) 
62 (6.1) 
72 (1.6) 
 
497 
39 
376 
 
30 (1.4) 
38 (6.1) 
27 (1.6) 
 
866 
61 
646 
 
63 (1.6) 
57 (7.0) 
68 (1.4) 
 
589 
44 
414 
 
36 (1.6) 
42 (7.0) 
31 (1.4) 
Polypharmacy*  
Yes  
No  
 
988 
725 
 
73 (1.7) 
67 (1.4) 
 
427 
485 
 
26 (1.7) 
33 (1.4) 
 
988 
586 
 
73 (1.7) 
56 (1.6) 
 
427 
621 
 
26 (1.7) 
44 (1.6) 
Prescription medications use*  
Yes  
No  
 
1574 
139 
 
72 (1.3) 
56 (4.8) 
 
774 
135 
 
28 (1.3) 
44 (4.8) 
 
1574 
0 
 
72 (1.3) 
0 
 
774 
274 
 
27 (1.3) 
100 (0) 
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Characteristic  DS use in the past 30 days  Use of Prescription medications  with 
DS in the past 30 days  
Yes 
Freqa    W.%(SE)b 
No 
Freqa    W.%(SE)b 
Yes 
Freqa    W.%(SE)b 
No 
Freqa    W.%(SE)b 
Source of DS* 
Decided to take it for reasons of my 
own 
A doctor or other health provider 
advised me to take it 
 
905 
 
540 
 
63 (2.1) 
 
37 (2.1) 
 
 
0 
 
0 
 
0 
 
0 
    
*Significant values at 0.05 level of significant using Chi square p-value. a Sample frequency. b Weighted percentage and Standard 
errors. 
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Prevalence of use of specific types of dietary supplements and the most commonly reported 
reason for use of each product among older adults 
    In this section, the trends in use of each type of DS and the most common reported reason for 
use of each DS among older adults will be presented. Multi-vitamin and multi-minerals 
(MVMM) was the most common type of DS use reported by older adults (23.18%) and the 
primary reason for use was “to maintain health or to stay healthy” (29%). The second most 
common DS used was calcium (17.05%) which was used mainly for “bone health” (70%). 
Vitamin D was the third most frequently used (10.30%) and was also used for “bone health” 
(31%). Vitamin C use was reported by 9.22% to “prevent cold” (45%), followed by Omega-3 
(8.44%) used mainly for “heart health and cholesterol” (40%). Vitamin B-12 was reported by 5% 
and was used mainly to “get more energy” (40%). Joint supplements, iron, botanicals, vitamin E, 
folic acid, multivitamins, magnesium, potassium, vitamin B-6, vitamin A, niacin, and fiber were 
the lowest DS reported by older adults used by 5% or less each. The complete list of DS use is 
reported in Table 4-5.  Women were more likely to use each of the DS types than men except for 
niacin, where men reported higher use.  
    In general, most older adults reported taking DS in the past 30 days in order to maintain their 
health or to stay healthy (18.15%).  The second most commonly reported reason was to improve 
overall health (17%), and the third most common reason was for bone health 15%. Other reasons 
for use are reported in Table 4-4.       
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Table 4-4 Prevalence of reported reasons for using DS among older adults in the United States, 
NHANES 2009-2012. 
 
Reported reason for DS use Frequency  Weighted % 
1-To maintain health (to stay healthy) 779 18.14 
2-To improve my overall health 692 16.73 
3-For bone health 653 14.96 
4-For heart health, cholesterol 337 8.44 
5-Other 324 7.76 
6-To supplement my diet, food not enough 259 5.73 
7-To get more energy 219 4.68 
8-For healthy joints, arthritis 202 4.62 
9-To prevent colds, boost immune system 186 5.00 
10- For eye health 145 3.53 
11-For anemia, such as low iron 113 1.98 
12-To prevent health problems 106 2.49 
13-For good bowel/colon health 74 2.01 
14-For skin health, dry skin 70 1.75 
15-For muscle related issues 47 1.38 
16-For mental health 38 0.60 
17-For weight loss 10 0.11 
18-For teeth, prevent cavities 1 0.00 
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Table 4-5 Prevalence of use for each supplement and the most common reason reported for each type of supplement among older adults (65 
years and older), NHANES 2009-2012. 
Type of 
Supplement  
Overall (N & 
W.%)¶ 
n= 2489 
Men (N & W.%)¶ 
n= 1005 
Women (N & W.%)¶ 
n= 1484 
Most common reported reason for use Users reporting 
this reason W.% ¶ 
MVMM 574 (23.06) 275 (48) 299 (52) To improve my overall health 31 
Calcium 430 (17.27) 117 (27.20) 313 (72.9) For bone health 73 
Vitamin D 256 (10.28) 100 (39) 156 (61) For bone health 32 
Vitamin C 229 (9.20) 97 (42.35) 132 (57.64) To prevent colds, boost immune system 45 
Fiber  209 (8.39) 98 (46.88)  111 (53.11) For good bowel/colon health 64 
Vitamin B12 121 (4.86) 52 (43) 69 (57) To get more energy 33 
Niacin  116 (4.66) 57 (49.13) 59 (50.86) For heart health, cholesterol 86 
Omega-3/Fish oil 106 (4.25) 37 (35) 69 (65) For heart health, cholesterol 45 
Multivitamins  85 (3.41) 41 (48.23)  44 (51.76) To maintain health (to stay healthy) 33 
Vitamin E 82 (3.29) 22 (26.82) 60 (73.17) For heart health, cholesterol 24 
Iron 76 (3.05) 31 (40.78) 45 (59.21) For anemia, such as low iron 63 
Joint Supplements 59 (2.37) 23 (39) 36 (61) For healthy joints, arthritis 57 
Potassium  40 (1.60) 14 (35) 26 (65)  For muscle related issues 29.5 
Folic Acid  33 (1.32) 11 (33.33) 22 (66.66)  To maintain health (to stay healthy) 26.5 
Vitamin B6 31 (1.24) 13 (42)  18 (58)  To improve my overall health 19 
Vitamin A 18 (0.72) 5 (27.77)  13 (72.22)  For eye health 38.5 
Magnesium 13 (0.52) 7 (54)  6 (46)  For bone health 27 
Botanicals 11 (0.44) 5 (45.45)  6 (54.55)  For heart health, cholesterol 24 
¶ Sample size and weighted percentage.  
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The relationship between dietary supplement use and demographic and socioeconomic 
characteristics among older adults 
    A logistic regression model was built to predict the factors that are associated with DS use 
among older adults. After reviewing bivariate analyses and checking that model assumptions 
were met, the final model was selected and is reported in Table 4-6. Outliers were assessed and 
multicollinearity was tested as well and results are shown in the Appendix. Out of 12 predictors 
evaluated in the logistic regressions model, eight predictors were significantly associated with 
DS use in the past 30 days among older adults participants. Age, sex, race, annual family 
income, health status, using medication in the past 30 days, and polypharmacy were significantly 
associated with using DS among older adults. For every one year increase after 65 years the odds 
of using DS increased by 1.032 (1.004-1.065). Females were 53% more likely to use DS in the 
past month compared to male participants OR=1.533 (1.164-2.019). Non-hispanic whites were 
significantly more likely to report using DS than non-hispanic blacks or Mexican Americans 
(OR= 0.596 (0.435-0.817) and 0.621 (0.472-0.816) respectively). Those who reported a normal 
BMI were 32% more likely to report using DS than overweight older participants OR=1.326 
(1.037-1.697). Those who reported their health status as fair or poor were significantly less likely 
to use DS compared to those who reported good health OR=0.576 (0.415-0.801). Using prescription 
medications in the past 30 days was significantly associated with reporting DS use compared to those not 
using prescription medications in the past month OR=1.77 (1.146-2.757). This means those who were 
using prescription medication in the past 30 days were 77% more likely to use DS than those who were 
not taking prescription medications in the past 30 days. Finally, those who were taking 4 or more 
prescription medications were 34% more likely to use DS than those who were taking less than 4 
prescription medications OR=1.347 (1.012-1.793). All the results were adjusted to age, sex, race, 
 
 
43 
   
education, BMI, marital status, family income, hypertension diagnosis, health status, prescription 
medications use, and polypharmacy.  
Table 4-6 Logistic regression model of DS use among older adults, NHANES 2009-2012. 
Factors  Adjusted OR (95% CI)¶   
Age (continuous)  1.032 (1.004-1.065)* 
Sex  
Male  
Female 
 
Reference 
1.533 (1.164-2.019)*  
Race 
Non-Hispanic White  
Non-Hispanic Black 
Mexican American & other Hispanic 
Other  
 
Reference 
0.596 (0.435-0.817)* 
0.621 (0.472-0.816)* 
0.643 (0.322-1.285) 
Education 
High school or less  
College degree 
Higher degree  
 
Reference 
1.259 (0.852-1.861) 
1.348 (0.988-1.841) 
BMI 
Overweight  
Underweight  
Normal  
Obese  
 
Reference 
1.563 (0.634-3.850) 
1.326 (1.037-1.697)* 
0.946 (0.658-1.359) 
Marital Status  
Married  
Never married  
Divorced/Separated/Widowed  
 
Reference 
0.748 (0.441-1.267) 
1.121 (0.853-1.474) 
Family Income  
Low  
Middle  
High  
 
Reference 
1.452 (1.142-1.846)* 
1.379 (0.931-2.042) 
Systolic/Diastolic Elevation  
No 
Yes    
 
Reference 
1.028 (0.805-1.312) 
Health Status  
Good  
Excellent/very good 
Fair or poor  
 
Reference 
1.003 (0.794-1.266) 
0.576 (0.415-0.801)* 
Prescription Medication Use 
No 
Yes  
 
Reference 
1.778 (1.146-2.757)* 
Polypharmacy  
No 
Yes 
 
Reference 
1.347 (1.012-1.793)* 
*Significant values at 0.05 level of significance.  
¶ Adjusted odds ratio and 95% confident interval.  
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CHAPTER 5: DISCUSSION 
    This cross sectional study was conducted to determine the trends of DS use among the 
younger and older adult population in the U.S. using nationally representative data (NHANES 
2009-2012). Also, one of the main objectives of this study was to evaluate the most common 
reasons behind using DS among older adults and the factors associated with DS use in the past 
30 days. Moreover, this is the first study to focus specifically on older adults (65 years and 
older). Main findings, strengths, limitations, future directions, and conclusion will be discussed 
in this chapter.     
Trends in DS use 
    Out of 14,000 participants in the two NHANES cohorts 2009-2012, 51% of those participants 
reported using DS in the past 30 days among all ages 20 years and older, an increase of 3% over 
the previous study using NHANES 2007-2010 (Bailey et al., 2013). Among the younger adult 
population (20-64 years old), 47% used at least one DS in the past month.  The percentage using 
at least one DS in the past 30 days increased to 70.5% among older adults and this was higher 
than in the NHANES 2007-2010 cohort where 67% reported DS use in the past 30 days (Bailey 
et al., 2013). In our study, MVMM was the most common reported DS taken in the past 30 days 
by the younger adult population (20-64 years of age) and older adults (65 years and older). 
Thirty percent of the U.S. younger adult population reported using MVMM, while 23% of older 
adults reported using MVMM. Calcium, vitamin D, vitamin C, and fiber were among the most 
frequently reported DS used by the older adult population with 17%, 10%, 9%, and 8% of older 
adults using these supplements respectively.  In contrast, MVMM, calcium, omega-3, botanicals, 
and vitamin C were the top reported DS in the recent study using the 2007-2010 cohort (Bailey 
et al., 2013). Potassium, folic acid, vitamin B6, vitamin A, magnesium, and botanicals had the 
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lowest reported use among older adults (1.6%, 1.3%, 1.2%, 0.72%, 0.52%, and 0.44% 
respectively).         
Rationale for using DS among older adults 
    For this specific aim, only the older adult population (65 years and older) was considered. This 
is the first study that focused on older adults specifically to determine the most common reasons 
for using DS. The most common reason reported for using DS in the past 30 days by older adults 
was to “Maintain their health/to stay healthy” (18.15%), followed by “To improve overall 
health” (17%). Fifteen percent of older adults reported using DS for “bone health” and 8.5% of 
them for ”heart health and cholesterol”. These results are consistent with the recent study that 
was conducted by Bailey et al., (Bailey et al., 2013) where they evaluated all participants 20 
years of age and older in the 2007-2010 NHANES cohort. Also, for each dietary supplement, the 
most common reasons for use were explored. Niacin had the highest reported percentage (86%) 
for a single reason for use, which was for “heart health or cholesterol”, followed by calcium with 
73% for “bone health” and fiber with 64% for bowel health. Taking hypertension as an example 
to consider the opportunity for drug-supplement interactions or disease-supplement interactions 
in this study, 96% of older adults were taking antihypertensive medications at the same time 
there were high percentage of them taking niacin for heart health, which may lead to increase 
adverse drug reaction if a drug-supplement interaction is present. It is important to consider that 
DS can enter the market without clinical studies assuring the efficacy or safety of the 
supplement.  
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Polypharmacy and prescription medications 
    70% of older adult DS users consumed at least one prescription medication in the past 30 
days. This percentage is lower than the 90% of DS users who reported using prescription 
medication in the GEM study (Nahin et al., 2009). Seventy one percent of the oldest old (80 
years) reported using both prescription medication and DS in the past 30 days. The majority of 
older participants who used four or more prescription medications reported using DS in the past 
30 days. Polypharmacy itself is a major health issue among older adults that may lead to serious 
health problem like falls, cognitive impairment, increase ER visits, and increased risk of drug-
drug interactions (Maher, Hanlon, & Hajjar, 2014). Taking DS concurrently with multiple 
medications may increase the chance of DS-drug interactions. For instance, in our study the 
majority of older participants reported using calcium, which may interact with quinolone 
antibiotic medications, thyroid medications or antiviral medications. Vitamin D was one of the 
highest reported products in our study, which may interact with steroid medications. Vitamin C 
may interact with amphetamine products. Moreover, supplements that contain calcium, 
magnesium, gingko, and iron (Tsai, Lin, Simon Pickard, Tsai, & Mahady, 2012) are particularly 
associated with a higher risk of DS-drug interactions. Although many older adults choose to use 
DS because they believe that the DS is safe, there are side effects reported after using DS ranging 
from severe to moderate (Palmer et al., 2003). It is important to increase patient and health care 
provider awareness about DS efficacy and safety.  Thirty-five percent of DS users were taking 
supplements based on their physician’s advice and this percentage increased by 12% from that 
reported in the previous study of the 2007-2010 NHANES cohort (Bailey et al., 2013). Also, 
63% of DS users reported taking the supplement by their personal choice compared to 77% in 
the previous study (Bailey et al., 2013). Health care professionals are responsible to ask patients 
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about their DS and the reason behind using them in order to reduce the risk of adverse events and 
interactions and potentially to avoid unnecessary costs. 
Factors predicting using DS for older adults 
    In our study we found that being older, female, non hispanic white, normal weight, middle 
income, having excellent or good reported health status, using at least one prescription 
medication in the past 30 days, and using 4 or more medications in the past month were 
significantly associated with using DS among older adult population in the U.S after adjusting 
for other variables. Most of the previous studies examining predictors of DS using mixed age 
groups of younger and older adults found similar results. Eileen et al. found in their study using 
NHANES  (2007-08) that there was an association between DS ues and being female, non-
hispanic white, and higher educated only (Eileen T. Kennedy, Hanqi Luo, 2013). The more 
recent study using the NHANES 2010 database by Bailey et al. (Bailey et al., 2013) reported that 
females, older adults, non-hispanic whites, normal or overweight individuals, and those with 
good or higher health status were more likely to use DS, which is similar to the findings reported 
in our study.         
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Strengths 
    This study aims to determine the prevalence of DS among adults of all ages and older adults 
specifically. Also, it aims to understand the rationale for older adults to use DS. Strengths of this 
study include:  
- A nationally representative cohort with large sample size was used, allowing study 
outcomes to be generalizable to the entire US.    
- To our knowledge, this is the first study evaluating the reasons for taking DS among the 
U.S. older adult population. 
- The most recently available NHANES database (2009-2010, 2011-2012) was used to 
conduct this study, making it the most up-to-date report about DS use in the U.S. 
- An analysis of major health problems like hypertension was evaluated for its association 
with using DS and for this specific predictor a measured variable rather than self reported 
questionnaire data was used, which increased the reliability of the results. Data that was 
related to hypertension was taking from MEC.    
Limitations 
    This study has several limitations. First, the analysis is based on data from a self-reported 
questionnaire, which may lead to overestimated or underestimated the prevalence. Also, different 
types of bias might be a problem here such as recall bias, behavioral bias, and selection bias. 
Second, participants in the NHANES study were only asked to report  DS use over a short period 
of time (last 30 days), which makes it difficult to determine if the DS was used for short-term or 
long-term use, unlike other studies that asked the subjects about DS use in the past 6 or 12 
months (Paula Gardiner et al., 2014). Third, reporting using DS or prescription medications does 
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not guarantee that the subject actually took the DS or medication. Finally, this is a cross-
sectional study and can only evaluate associations and the prevalence of DS use rather than any 
causal relationships.  
Future Directions 
    Future research should focus on DS safety and efficacy to establish whether Food and Drug 
Administration (FDA) oversight of DS is warranted. It is important to ensure that any product in 
the market is safe and effective particularly for the older adult population. Randomized 
controlled trials are expensive, but this is the best way to assess the efficacy and safety of each 
supplement. In addition, more investigations are needed to understand the healthcare provider 
knowledge and behavior regarding DS and alternative medicine. NHANES does not ask about 
pharmacist recommendations regarding DS and this is also an important area of future study.  
Studying DS use among assisted living facility residents and nursing home residents is also 
needed area of future study, as these patients are more likely to be frail and have compromised 
health and functional status. 
Conclusion  
    In conclusion, a high percentage of older adults reported using DS in the past 30 days. 
Similarly, a high percentage of older adults reported using DS concurrently with prescription 
medications. Using DS was significantly higher among female, non-hispanic white, normal 
weight, middle-income, polypharmacy patients, prescription medication users, and self-reported 
excellent or good health status. Including questions related to DS use in patient medication 
history in the medical record and carefully evaluating this DS use is important in order to deliver 
safe and cost effective health care.       
 
 
50 
   
References 
Bailey, R. L., Gahche, J. J., Lentino, C. V, Dwyer, J. T., Engel, J. S., Thomas, P. R., … Picciano, 
M. F. (2011). Dietary supplement use in the United States, 2003-2006. The Journal of 
Nutrition, 141(2), 261–6. doi:10.3945/jn.110.133025 
Bailey, R. L., Gahche, J. J., Miller, P. E., Thomas, P. R., & Dwyer, J. T. (2013). Why US adults 
use dietary supplements. JAMA Internal Medicine, 173(5), 355–61. 
doi:10.1001/jamainternmed.2013.2299 
Bikowski, R. M., Ripsin, C. M., & Lorraine, V. L. (2001). Physician-patient congruence 
regarding medication regimens. Journal of the American Geriatrics Society, 49, 1353–1357. 
doi:10.1046/j.1532-5415.2001.49265.x 
Brazier, N. C., & Levine, M. a H. (2003). Drug-herb interaction among commonly used 
conventional medicines: a compendium for health care professionals. American Journal of 
Therapeutics, 10(3), 163–169. doi:10.1097/00045391-200305000-00003 
Eileen T. Kennedy, Hanqi Luo, and R. F. H. (2013). Dietary Supplement Use Pattern of U.S. 
Adult Population in the 2007-2008 National Health and Nutrition Examination Survey 
(NHANES). Ecology of Food and Nutrition, 52(804), 76–84. 
Fulton, M. M., & Allen, E. R. (2005). Polypharmacy in the elderly: a literature review. Journal 
of the American Academy of Nurse Practitioners, 17, 123–132. 
doi:10.3109/13814780009069956 
Gahche, J., Bailey, R., Ph, D., Burt, V., Sc, M., Hughes, J., … Sempos, C. (2011). Dietary 
Supplement Use Among U . S . Adults Has Increased Since NHANES III ( 1988 – 1994 ), 
(61). 
Gardiner, P., Graham, R. E., Legedza, A. T. R., Eisenberg, D. M., & Phillips, R. S. (2006). 
Factors associated with dietary supplement use among prescription medication users. 
Archives of Internal Medicine, 166(18), 1968–1974. Retrieved from 
http://proxy.library.vcu.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&
AuthType=ip,url,cookie,uid&db=ccm&AN=2009314297&site=ehost-live&scope=site 
Gardiner, P., Graham, R. E., Legedza, A. T. R., Eisenberg, D. M., Phillips, R. S., & Deaconess, 
B. I. (2014). Factors Associated With Dietary Supplement Use Among Prescription 
Medication Users, 166. 
Hajjar, E. R., Cafiero, A. C., & Hanlon, J. T. (2007). Polypharmacy in elderly patients. The 
American Journal of Geriatric Pharmacotherapy, 5(4), 345–51. 
doi:10.1016/j.amjopharm.2007.12.002 
 
 
51 
   
Jacobsen, L. a, Kent, M., Lee, M., & Mather, M. (2011). America’s aging population. Population 
Bulletin, 66(1), 1–18. 
Maher, R. L., Hanlon, J., & Hajjar, E. R. (2014). Clinical consequences of polypharmacy in 
elderly. Expert Opinion on Drug Safety, 13(1), 57–65. doi:10.1517/14740338.2013.827660 
Mallet, L., Spinewine, A., & Huang, A. (2007). The challenge of managing drug interactions in 
elderly people. Lancet, 370, 185–191. doi:10.1016/S0140-6736(07)61092-7 
Nahin, R. L., Pecha, M., Welmerink, D. B., Sink, K., DeKosky, S. T., & Fitzpatrick, A. L. 
(2009). Concomitant use of prescription drugs and dietary supplements in ambulatory 
elderly people. Journal of the American Geriatrics Society, 57(7), 1197–1205. 
doi:10.1111/j.1532-5415.2009.02329.x 
National Health and Nutrition Examination Survey : Plan and Operations , 1999 – 2010. (2010), 
1999–2010. 
National Social Life, Health, and Aging Project (NSHAP), NORC.org. (2014). Retrieved March 
29, 2015, from http://www.norc.org/Research/Projects/Pages/national-social-life-health-
and-aging-project.aspx 
Palmer, M. E., Haller, C., McKinney, P. E., Klein-Schwartz, W., Tschirgi, A., Smolinske, S. C., 
… Landzberg, B. R. (2003). Adverse events associated with dietary supplements: An 
observational study. Lancet, 361, 101–106. doi:10.1016/S0140-6736(03)12227-1 
Q&A on Dietary Supplements. (2014). Retrieved September 3, 2014, from 
http://www.fda.gov/food/dietarysupplements/qadietarysupplements/ 
Qato, D. M., Alexander, G. C., Conti, R. M., Johnson, M., Schumm, P., & Lindau, S. T. (2008). 
Use of prescription and over-the-counter medications and dietary supplements among older 
adults in the United States. JAMA : The Journal of the American Medical Association, 
300(24), 2867–78. doi:10.1001/jama.2008.892 
Qato, D. M., Alexander, G. C., Conti, R. M., Johnson, M., Schumm, P., & Lindau, S. T. (2014). 
Use of Prescription and Over-the-counter Medications and Dietary Supplements Among 
Older Adults in the United States, 300(24), 2867–2878. 
Questions and Answers: Ginkgo biloba for the Evaluation of Memory (GEM) Study, NCCIH. 
(2014). Retrieved March 5, 2015, from 
https://nccih.nih.gov/research/results/gems/qa.htm#q3 
Richard.L., N., Monica., P., Diana.B., W., Kaycee., S., Steven.T., D., & Annette.L., F. (2009). 
Concomitant use of prescription drugs and dietary supplements in ambulatory elderly 
people: Clinical investigations. Journal of the American Geriatrics Society, 57(7), 1197–
1205. doi:10.1111/j.1532-5415.2009.02329.x 
 
 
52 
   
Riker, G. I., & Setter, S. M. (2012). in Older Adults at Home, 474–485. 
Services, H. (1997). National Health Interview Survey. Medicine, 29(Supplement), 190–195. 
doi:10.1097/00005768-199706001-00029 
States, U., & Accountability, G. (2009). DIETARY SUPPLEMENTS FDA Should Take Further 
Actions to Improve Oversight and Consumer Understanding H ighlights FDA S hould Take 
Further Action s to Improve, (January). 
Tsai, H. H., Lin, H. W., Simon Pickard, a., Tsai, H. Y., & Mahady, G. B. (2012). Evaluation of 
documented drug interactions and contraindications associated with herbs and dietary 
supplements: A systematic literature review. International Journal of Clinical Practice, 
66(November), 1056–1078. doi:10.1111/j.1742-1241.2012.03008.x 
 
 
 
 
 
53 
   
Appendix 
Multicollinearity checking:  
Pearson Correlation Coefficients  
Prob > |r| under H0: Rho=0  
Number of Observations 
 SEX RACE Education BMI Marital_status Family_income HTN health_status RX Polypharmacy 
SEX 
1.00000 
 
20293 
 
0.00616 
0.3800 
20293 
 
0.02164 
0.0190 
11758 
 
0.03137 
<.0001 
18011 
 
0.13513 
<.0001 
11767 
 
-0.03012 
<.0001 
19323 
 
0.02544 
0.0020 
14801 
 
0.04706 
<.0001 
12449 
 
-
0.06777 
<.0001 
20282 
 
-0.02784 
<.0001 
20293 
 
RACE 
0.00616 
0.3800 
20293 
 
1.00000 
 
20293 
 
-
0.06083 
<.0001 
11758 
 
-
0.10925 
<.0001 
18011 
 
-0.04368 
<.0001 
11767 
 
-0.06562 
<.0001 
19323 
 
0.04479 
<.0001 
14801 
 
0.10692 
<.0001 
12449 
 
0.18924 
<.0001 
20282 
 
0.13004 
<.0001 
20293 
 
Education 
0.02164 
0.0190 
11758 
 
-
0.06083 
<.0001 
11758 
 
1.00000 
 
11758 
 
-
0.09816 
<.0001 
11214 
 
-0.09551 
<.0001 
11748 
 
0.38800 
<.0001 
11176 
 
0.08703 
<.0001 
10823 
 
-0.31554 
<.0001 
10039 
 
0.00235 
0.7986 
11750 
 
0.09395 
<.0001 
11758 
 
BMI 
0.03137 
<.0001 
18011 
 
-
0.10925 
<.0001 
18011 
 
-
0.09816 
<.0001 
11214 
 
1.00000 
 
18011 
 
0.01077 
0.2538 
11223 
 
-0.02592 
0.0007 
17188 
 
-
0.15078 
<.0001 
14652 
 
0.22275 
<.0001 
12310 
 
-
0.28370 
<.0001 
18002 
 
-0.27617 
<.0001 
18011 
 
Marital_status 
0.13513 
<.0001 
11767 
 
-
0.04368 
<.0001 
11767 
 
-
0.09551 
<.0001 
11748 
 
0.01077 
0.2538 
11223 
 
1.00000 
 
11767 
 
-0.25490 
<.0001 
11184 
 
-
0.07950 
<.0001 
10832 
 
0.09505 
<.0001 
10046 
 
-
0.08220 
<.0001 
11759 
 
-0.11255 
<.0001 
11767 
 
 
 
54 
   
Pearson Correlation Coefficients  
Prob > |r| under H0: Rho=0  
Number of Observations 
 SEX RACE Education BMI Marital_status Family_income HTN health_status RX Polypharmacy 
Family_income 
-
0.03012 
<.0001 
19323 
 
-
0.06562 
<.0001 
19323 
 
0.38800 
<.0001 
11176 
 
-
0.02592 
0.0007 
17188 
 
-0.25490 
<.0001 
11184 
 
1.00000 
 
19323 
 
0.05333 
<.0001 
14151 
 
-0.23525 
<.0001 
11910 
 
-
0.01969 
0.0062 
19313 
 
0.05813 
<.0001 
19323 
 
HTN 
0.02544 
0.0020 
14801 
 
0.04479 
<.0001 
14801 
 
0.08703 
<.0001 
10823 
 
-
0.15078 
<.0001 
14652 
 
-0.07950 
<.0001 
10832 
 
0.05333 
<.0001 
14151 
 
1.00000 
 
14801 
 
-0.11234 
<.0001 
12145 
 
0.19845 
<.0001 
14793 
 
0.18790 
<.0001 
14801 
 
health_status 
0.04706 
<.0001 
12449 
 
0.10692 
<.0001 
12449 
 
-
0.31554 
<.0001 
10039 
 
0.22275 
<.0001 
12310 
 
0.09505 
<.0001 
10046 
 
-0.23525 
<.0001 
11910 
 
-
0.11234 
<.0001 
12145 
 
1.00000 
 
12449 
 
-
0.16008 
<.0001 
12442 
 
-0.24404 
<.0001 
12449 
 
RX 
-
0.06777 
<.0001 
20282 
 
0.18924 
<.0001 
20282 
 
0.00235 
0.7986 
11750 
 
-
0.28370 
<.0001 
18002 
 
-0.08220 
<.0001 
11759 
 
-0.01969 
0.0062 
19313 
 
0.19845 
<.0001 
14793 
 
-0.16008 
<.0001 
12442 
 
1.00000 
 
20282 
 
0.47547 
<.0001 
20282 
 
Polypharmacy 
-
0.02784 
<.0001 
20293 
 
0.13004 
<.0001 
20293 
 
0.09395 
<.0001 
11758 
 
-
0.27617 
<.0001 
18011 
 
-0.11255 
<.0001 
11767 
 
0.05813 
<.0001 
19323 
 
0.18790 
<.0001 
14801 
 
-0.24404 
<.0001 
12449 
 
0.47547 
<.0001 
20282 
 
1.00000 
 
20293 
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Checking Outliers 
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